Gema L. Ramírez-Vil on Muck Rack

Gema L. Ramírez-Vil

As seen in: European Journal of Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Gema L.

Contact Gema L., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

|
By Alissa Groenendijk, Harm van Tinteren, Yilin Jiang, Gordan M. Vujanić, Christian Rübe, Carlo Morosi, Kathy Pritchard-Jones, Reem Al-Saadi, Sucheta J. Vaidya, Arnauld C. Verschuur, Jan Godzinski, Jens-Peter Schenk, Gema L. Ramírez-Vil
| European Journal of Cancer
Highlights • On behalf of the Society of International Pediatric Oncology- Renal Tumor Study Group. • Risk stratification of relapsed Wilms tumour is based on primary treatment intensity. • Patients treated with vincristine and actinomycin-D are advised a four-drug therapy at relapse. • A three-drug therapy is adequate relapse treatment in a subset of patients. • Identification of this subset requires large-scale epidemiological and molecular studies.
Open in Who Shared Issue with article?
See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Gema L.

Contact Gema L., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified